Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes

NCT06923488 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: Leflunomide 10mg
DRUG: Leflunomide 20mg
DRUG: Decitabine

Sponsor

West Virginia University